CCND1 and EH37E0225350 endogenous expression was shown to be dependent on estrogen signaling, indicating that the active EH37E0225350 enhancer may be necessary for the activation of CCND1 expression by estrogen in breast cancer cells34. Here, CCND1 is linked to breast carcinoma.